Navigation Links
Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
Date:11/15/2012

BALTIMORE, Md., Nov. 15, 2012 /PRNewswire/ -- Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., was named the inaugural Ernst & Young U.S. 2012 Family Business Award of Excellence winner today at Ernst & Young LLP's 2012 Strategic Growth Forum in Palm Springs, CA.

Gupta was born into the pharmaceutical business, but it was her guidance and vision that established Lupin Pharmaceuticals, Inc. ("LPI") as the U.S. wholly owned subsidiary of Lupin Ltd., the company founded by her father. Today, LPI provides quality branded and generic medications in the United States. She was honored at a special luncheon as the inaugural recipient of the Family Business Award of Excellence. This award recognized an entrepreneurial venture that is led by a second or later generation family member or multiple members of family, with plans to carry the business forward for future generations.

"Gupta's father, Desh Bandhu Gupta, founded India's Lupin Ltd. in 1968, and as a teenager she accompanied him on business trips around the world, giving her a taste of global diplomacy and negotiation strategy," said Bryan Pearce, Americas Director, Entrepreneur Of The Year, Ernst & Young LLP. "Through these early valuable experiences with her father, and her continued education in business, education, and pharmaceuticals, Vinita has come to be a great leader who will continue to take Lupin Pharmaceuticals to new heights."

Returning to the nest with new strategies

After completing school at the University of Mumbai, Gupta, initially a pharmacist by trade, moved to the United States to pursue an MBA at Northwestern's Kellogg School of Management. Upon graduating, she went to work for a large U.S. pharmaceutical company before quickly realizing that the day-to-day monotony was not for her. She returned to India in 1992 with a mission: to use her extensive knowledge of the Lupin business and the skills acquired during her time in the U.S. to develop a plan for expanding the family business into the U.S. and European markets.

LPI now has 40 generic products on the market. Approximately half of these products are the market leaders, and almost all of them are in the top three of market share. LPI is ranked in the top five U.S. drug companies by prescriptions sold and is the fastest growing of the top 10. The company has a remarkable customer service level due to the seamless integration of its products and its thorough understanding of the customs in both India and the U.S.

As the company has grown, Gupta has built a team to manage the daily operations, including branding, sales, supply chain, pursuits and company culture. Many of the people added to her team were based on recommendations from customers. Her goal is to hire employees with a mindset similar to that of the existing company culture. Gupta's team is entrepreneurial and works hard to develop smart growth using creative thinking when needed. Gupta's next challenge is finding a balance between work and life to spend more time with her own son.

Video and photos

To view video clips of all of the Entrepreneur Of The Year winners, please visit ey.com/us/eoy. Photos of the winners are also available by request.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored in the United States by SAP America and the Ewing Marion Kauffman Foundation.

About Ernst & Young LLP's Strategic Growth Markets practice

Ernst & Young LLP's Strategic Growth Markets (SGM) practice guides leading high-growth companies. Our multidisciplinary team of elite professionals provides perspective and advice to help our clients accelerate market leadership. SGM delivers assurance, tax, transactions and advisory services to thousands of companies spanning all industries. Ernst & Young is the undisputed leader in taking companies public, advising key government agencies on the issues impacting high-growth companies and convening the experts who shape the business climate. For more information, please visit us at ey.com/us/strategicgrowthmarkets, or follow news on Twitter at EY_Growth.

About Ernst & Young

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 167,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

For more information, please visit ey.com.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.

This news release has been issued by Ernst & Young LLP, a client-serving member firm of Ernst Young Global Limited operating in the US.

 

 


'/>"/>
SOURCE Ernst & Young LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The University of Munich Hospital and Clinics Selects Brainlab Buzz Digital O.R. to Equip All 32 Operating Rooms in New Grobhadern Surgical Building
2. STAAR Surgical Expands Footprint for Growth with Lease on Adjacent Building in Monrovia, California
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
5. Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
6. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
7. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
9. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
10. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
11. MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... March 28, 2017 RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Japan Patent Office (JPO) for the composition ... factor (CTGF) for the treatment or prevention of ... fibrosis and proliferative retinopathy (Japanese Patent #: 6060071).  ...
(Date:3/28/2017)... 2017 The global flow ... billion by 2025, according to a new study by ... diseases and cancer is expected to upsurge the demand ... the coming years. In addition, higher number of physicians ... stem cell therapy, due to adverse effects caused by ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... MA (PRWEB) , ... March 28, 2017 , ... ... for direct measurement of corrosive ions found in power plant water and steam. ... components such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. ...
(Date:3/28/2017)... ... 2017 , ... A minimally invasive porcelain veneer is increasing ... Association of Dental Laboratories (NADL) is informing dentists about the benefits of minimally ... dental laboratories and technicians that create these veneers. , According to National ...
(Date:3/28/2017)... NJ (PRWEB) , ... March 28, 2017 , ... ... Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was a busy ... their team of professional staff discussed strategies for preventing outbreaks among camp communities ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium ... providers and offered an opportunity to collaborate and network with healthcare colleagues across the ... attendees gathered for a lively discussion on trends and issues that healthcare leaders will ...
Breaking Medicine News(10 mins):